Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) Income towards Parent Company (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Income towards Parent Company for 4 consecutive years, with $601.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income towards Parent Company changed N/A year-over-year to $601.0 million, compared with a TTM value of $2.2 billion through Dec 2025, up 64.05%, and an annual FY2023 reading of -$4.0 million, down 122.22% over the prior year.
  • Income towards Parent Company was $601.0 million for Q4 2025 at GE HealthCare Technologies, up from $465.0 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $601.0 million in Q4 2025 and bottomed at -$4.0 million in Q3 2023.
  • Average Income towards Parent Company over 4 years is $397.9 million, with a median of $435.0 million recorded in 2024.
  • The sharpest move saw Income towards Parent Company dropped 10.91% in 2023, then surged 12350.0% in 2024.
  • Year by year, Income towards Parent Company stood at $6.0 million in 2022, then crashed by 166.67% to -$4.0 million in 2023, then soared by 12350.0% to $490.0 million in 2024, then increased by 22.65% to $601.0 million in 2025.
  • Business Quant data shows Income towards Parent Company for GEHC at $601.0 million in Q4 2025, $465.0 million in Q3 2025, and $500.0 million in Q2 2025.